Loading...

Intellectia LogoIntellectia
AI Trading Bot
Features
Markets
News
Resources
Pricing
Get Started
  1. Home
  2. ETF
  3. PSTV
PSTV logo

PSTV

-
$
0.000
0.000(0.000%)
At close
0.000(0.000%)Aft-market
ET
$
0.000
0.000(0.000%)
At close
0.000(0.000%)Aft-market
ET
OverviewTechnicalNews
an image of Intellectia Logoan image of Intellectia

Most Trusted AI Platform for Winning Trades

TwitterYoutubeQuoraDiscordLinkedinTelegram

Copyright © 2026 Intellectia.AI. All Rights Reserved.

Company

  • Home
  • Contact
  • About Us
  • Press
  • Privacy
  • Terms of Service
  • Service Terms of Use

Resources

  • Blog
  • Tutorial
  • Help Center
  • Affiliate Program

Markets

  • Market Analysis
  • Crypto
  • Featured Screeners
  • AI Earnings Calendar
  • Market Movers
  • Stock Monitor
  • Economic Calendar
  • All US Stocks
  • All Cryptos

Tools

  • Dividend Calculator
  • Dividend Yield Calculator
  • Options Profit Calculator

Features

  • QuantAI Alpha Pick
  • SwingMax Portfolio
  • Swing Trading
  • AI Stock Picker
  • Whales Auto Tracker
  • Daytrading Center
  • Patterns Detection
  • AI Screener
  • Financial AI Agent
  • Backtesting Playground
  • AI Earnings Prediction
  • Stock Monitor
  • Technical Analysis

News

  • Overview
  • Top News
  • Daily Market Brief
  • Earnings Analysis
  • Newswire
  • Stock News
  • Crypto News
  • Institution News
  • Congress News
  • Monitor News

Compare

  • TradingView
  • SeekingAlpha
Intellectia

PSTV News

Plus Therapeutics Presents REYOBIQ Clinical Data at AANS Annual Meeting

3d agoNewsfilter

Plus Therapeutics Secures Medicare Enrollment for CNSide Diagnostics

4d agoNewsfilter

CNSide Diagnostics Secures Coverage Agreement with Blue Shield of California

Apr 28 2026Newsfilter

Plus Therapeutics Initiates Manufacturing Activities with SpectronRx

Apr 23 2026Newsfilter

Plus Therapeutics Appoints New Chief Development Officer

Apr 22 2026Newsfilter

Plus Therapeutics Stock Meets Nasdaq Minimum Bid Requirement

Apr 21 2026seekingalpha

Plus Therapeutics Regains Nasdaq Compliance with Minimum Bid Price

Apr 21 2026Newsfilter

Plus Therapeutics Appoints New VP of Value Strategy

Apr 15 2026Newsfilter

Plus Appoints New Chief Development Officer and Receives FDA Approval

Apr 10 2026stocktwits

Plus Therapeutics Appoints New Chief Development Officer

Apr 09 2026Newsfilter

Plus Therapeutics Receives FDA Orphan Drug Designation

Apr 08 2026Newsfilter

Plus Therapeutics Secures New CPT Code for CNSide Test

Apr 07 2026Newsfilter

Plus Therapeutics Secures New Payer Agreement with Highmark

Apr 02 2026Newsfilter

Plus Therapeutics Grants Inducement Awards to New Employees

Mar 31 2026Newsfilter

Plus Therapeutics Announces 1-for-25 Reverse Stock Split

Mar 31 2026seekingalpha

Plus Therapeutics Approves 1-for-25 Reverse Stock Split

Mar 31 2026Newsfilter